Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis

Table 10 Demographic baseline data of non-acute and acute decompensating patients

	NAD-decompensating patients (n = 29)	AD-decompensating patients (n = 14)	P value
Male [n (%)]	16 (55.2)	6 (42.9)	NS1
Female [n (%)]	13 (44.8)	8 (57.1)	NS1
Age (mean ± SD)	64.79 ± 12.34	69.93 ± 10.91	NS2
Child-Pugh Grade A [n (%)]	9 (31.1)	3 (21.4)	NS1
Child-Pugh Grade B [n (%)]	20 (68.9)	11 (78.6)	NS1

¹Chi-square test.

²Mann-Whitney U test.

Statistically significant differences (P < 0.05) are reported in bold; NS: Not statistically significant; AD: Acute decompensation; NAD: Non-acute decompensation.